US EditionFetterman pushes for Medicare to cover GLP-1s
- Senator John Fetterman discussed his positive experience with Mounjaro, stating that it significantly improved his overall health and well-being.
- Fetterman noted that he has lost around 20 pounds and expressed that the medication can assist users in making meaningful lifestyle changes.
- The Centers for Medicare and Medicaid Services announced that Medicare would not cover GLP-1 medications like Mounjaro, despite their potential benefits for heart health and metabolic health.
- Experts have endorsed GLP-1 medications as important for managing type 2 diabetes and obesity, while noting that more studies are needed on their broader health benefits.
17 Articles
17 Articles
Diabetes and weight-loss drug ‘changed my life,’ says senator: ‘I feel a decade younger’
A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications. Doctors shared thoughts on the potential benefits.
Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities
Glucagon-like peptide-1 (GLP-1) analogs are approved for the treatment of obesity in adults and adolescents. Reports have emerged that the weight loss effect of these medications may be related to changes in food preferences and ingestive behaviors following the treatment. Understanding the mechanisms which impact ingestive behavior could expand opportunities to develop more refined and personalized treatment options for obesity. Recent studies …
Sen. Fetterman urges Trump not to abandon plan for Medicare, Medicaid coverage of weight-loss drugs
Sen. John Fetterman calls for affordable access to GLP-1 drugs like Ozempic and Wegovy, in a New York Times column, sharing his own health improvements from Mounjaro while criticizing the halt of expanded Medicare coverage.
Coverage Details
Bias Distribution
- 38% of the sources are Center, 38% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
